Emblica officinalis (Amla): A review of potential therapeutic applications
Abstract
healing, antidiarrheal, antiatherosclerotic, hepatoprotective, nephroprotective, and neuroprotective properties as demonstrated in numerous preclinical studies. Furthermore, experimental studies have reported that E. officinalis and some of its phytochemicals also exhibit anticarcinogenic properties. E. officinalis is also reported to possess radiomodulatory, chemomodulatory, chemopreventive, free radical scavenging, antioxidant, anti‑inflammatory, antimutagenic and immunomodulatory activities. These properties are efficacious
in the treatment and prevention of cancer. This review summarizes the results related to these properties and also emphasizes the aspects that warrant future research establishing its activity and utility as a cancer preventive and therapeutic drug in humans.
Key words: Amla, Emblica officinalis, Phyllanthus emblica, therapeutic applications
Full Text:
PDFReferences
Krishnaveni M, Mirunalini S. Therapeutic potential of Phyllanthus
emblica (amla): The ayurvedic wonder. J Basic Clin Physiol
Pharmacol 2010;21:93‑105.
Patel SS, Goyal RK. Emblica officinalis Geart: A Comprehensive
Review on Phytochemistry, Pharmacology and Ethnomedicinal
Uses. Res J Med Plant 2012;6:6‑16.
Baliga MS, Dsouza JJ. Amla (Emblica officinalis Gaertn), a wonder
berry in the treatment and prevention of cancer. Eur J Cancer Prev
;20:225‑39.
Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS,
Lele RD. Free radicals and antioxidants in human health:
Current status and future prospects. J Assoc Physicians India
;52:794‑804.
Poltanov EA, Shikov AN, Dorman HJ, Pozharitskaya ON,
Makarov VG, Tikhonov VP, et al. Chemical and antioxidant
evaluation of Indian gooseberry (Emblica officinalis Gaertn.,
syn. Phyllanthus emblica L.) supplements. Phytother Res
;23:1309‑15.
Reddy VD, Padmavathi P, Paramahamsa M, Varadacharyulu NC.
Amelioration of alcohol‑induced oxidative stress by Emblica
officinalis (amla) in rats. Indian J Biochem Biophys 2010;47:20‑5.
Shivananjappa MM, Joshi MK. Influence of Emblica officinalis
aqueous extract on growth and antioxidant defense system of
human hepatoma cell line (HepG2). Pharm Biol 2012;50:497‑505.
Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK.
Antioxidant activity of active tannoid principles of Emblica
officinalis (amla). Indian J Exp Biol 1999;37:676‑80.
Thyagarajan SP, Jayaram S, Gopalakrishnan V, Hari R,
Jeyakumar P, Sripathi MS. Herbal medicines for liver diseases in
India. J Gastroenterol Hepatol 2002;17:S370‑6.
Girish C, Pradhan SC. Indian herbal medicines in the treatment of
liver diseases: Problems and promises. Fundam Clin Pharmacol
;26:180‑9.
Chen KH, Lin BR, Chien CT, Ho CH. Emblica officinalis Gaertn.
attentuates N‑nitrosodiethylamine‑induced apoptosis, autophagy,
and inflammation in rat livers. J Med Food 2011;14:746‑55.
Sultana S, Ahmad S, Khan N, Jahangir T. Effect of Emblica
officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA
synthesis in Wistar rats. Indian J Exp Biol 2005;43:430‑6.
Tasduq SA, Kaisar P, Gupta DK, Kapahi BK, Maheshwari HS,
Jyotsna S, et al. Protective effect of a 50% hydroalcoholic fruit
extract of Emblica officinalis against anti‑tuberculosis drugs induced
liver toxicity. Phytother Res 2005;19:193‑7.
Damodara Reddy V, Padmavathi P, Gopi S, Paramahamsa M,
Varadacharyulu NCh. Protective effect of Emblica officinalis against
alcohol‑induced hepatic injury by ameliorating oxidative stress in
rats. Indian J Clin Biochem 2010;25:419‑24.
Reddy VD, Padmavathi P, Varadacharyulu NCh. Emblica officinalis
protects against alcohol‑induced liver mitochondrial dysfunction
in rats. J Med Food 2009;12:327‑33.
Mir AI, Kumar B, Tasduq SA, Gupta DK, Bhardwaj S, Johri RK.
Reversal of hepatotoxin‑induced pre‑fibrogenic events by Emblica
officinalis – A histological study. Indian J Exp Biol 2007;45:626‑9.
Sultana S, Ahmed S, Sharma S, Jahangir T. Emblica officinalis
reverses thioacetamide‑induced oxidative stress and early
promotional events of primary hepatocarcinogenesis. J Pharm
Pharmacol 2004;56:1573‑9.
Tasduq SA, Mondhe DM, Gupta DK, Baleshwar M, Johri RK.
Reversal of fibrogenic events in liver by Emblica officinalis (fruit),
an Indian natural drug. Biol Pharm Bull 2005;28:1304‑6.
Sharma A, Sharma MK, Kumar M. Modulatory role of Emblica
officinalis fruit extract against arsenic induced oxidative stress in
Swiss albino mice. Chem Biol Interact 2009;180:20‑30.
Muriel P, Rivera‑Espinoza Y. Beneficial drugs for liver diseases.
J Appl Toxicol 2008;28:93‑103.
Yokozawa T, Kim HY, Kim HJ, Tanaka T, Sugino H, Okubo T,
et al. Amla (Emblica officinalis Gaertn.) attenuates age‑related
renal dysfunction by oxidative stress. J Agric Food Chem
;55:7744‑52.
Chen TS, Liou SY, Chang YL. Supplementation of Emblica
officinalis (Amla) extract reduces oxidative stress in uremic patients.
Am J Chin Med 2009;37:19‑25.
Dwivedi S, Aggarwal A. Indigenous drugs in ischemic heart
disease in patients with diabetes. J Altern Complement Med
;15:1215‑21.
Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu DC, Juneja LR.
Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and
oxidative stress in the ageing process. Br J Nutr 2007;97:1187‑95.
Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study
of hypolipidemic efficacy of Amla (Emblica officinalis) with
‑hydroxy‑3‑methylglutaryl‑coenzyme‑A reductase inhibitor
simvastatin. Indian J Pharmacol 2012;44:238‑42.
Kim HJ, Yokozawa T, Kim HY, Tohda C, Rao TP, Juneja LR. Influence
of amla (Emblica officinalis Gaertn.) on hypercholesterolemia
and lipid peroxidation in cholesterol‑fed rats. J Nutr Sci
Vitaminol (Tokyo) 2005;51:413‑8.
Kim HY, Okubo T, Juneja LR, Yokozawa T. The protective role of
amla (Emblica officinalis Gaertn.) against fructose‑induced metabolic
syndrome in a rat model. Br J Nutr 2010;103:502‑12.
Duan W, Yu Y, Zhang L. Antiatherogenic effects of Phyllanthus
emblica associated with corilagin and its analogue. Yakugaku
Zasshi 2005;125:587‑91.
Patel SS, Goyal RK. Prevention of diabetes‑induced myocardial
dysfunction in rats using the juice of the Emblica officinalis fruit.
Exp Clin Cardiol 2011;16:87‑91.
Ojha S, Golechha M, Kumari S, Arya DS. Protective effect of Emblica
officinalis (amla) on isoproterenol‑induced cardiotoxicity in rats.
Toxicol Ind Health 2012;28:399‑411.
Srinivasan K. Plant foods in the management of diabetes mellitus:
Spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr
;56:399‑414.
Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla
fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile
of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr
;62:609‑16.
Tiwari V, Kuhad A, Chopra K. Emblica officinalis corrects functional,
biochemical and molecular deficits in experimental diabetic
neuropathy by targeting the oxido‑nitrosative stress mediated
inflammatory cascade. Phytother Res 2011;25:1527‑36.
Kumar NP, Annamalai AR, Thakur RS. Antinociceptive property
of Emblica officinalis Gaertn (Amla) in high fat diet‑fed/low dose
streptozotocin induced diabetic neuropathy in rats. Indian J Exp
Biol 2009;47:737‑42.
Chen TS, Liou SY, Wu HC, Tsai FJ, Tsai CH, Huang CY, et al.
Efficacy of epigallocatechin‑3‑gallate and Amla (Emblica officinalis)
extract for the treatment of diabetic‑uremic patients. J Med Food
;14:718‑23.
Kumar S, Gupta P, Sharma S, Kumar D. A review on
immunostimulatory plants. Zhong Xi Yi Jie He Xue Bao
;9:117‑28.
Suresh K, Vasudevan DM. Augmentation of murine natural killer
cell and antibody dependent cellular cytotoxicity activities by
Phyllanthus emblica, a new immunomodulator. J Ethnopharmacol
;44:55‑60.
Sai Ram M, Neetu D, Yogesh B, Anju B, Dipti P, Pauline T,
et al. Cyto‑protective and immunomodulating properties of
Amla (Emblica officinalis) on lymphocytes: An in‑vitro study.
J Ethnopharmacol 2002;81:5‑10.
Mahady GB. Medicinal plants for the prevention and treatment
of bacterial infections. Curr Pharm Des 2005;11:2405‑27.
Rahman S, Akbor MM, Howlader A, Jabbar A. Antimicrobial and
cytotoxic activity of the alkaloids of Amlaki (Emblica officinalis).
Pak J Biol Sci 2009;12:1152‑5.
Vijayalakshmi S, Arunkumar V, Anju D, Gunasundari P,
Moorthy P, Chandrasekharan AK. Comparative antimicrobial
activities of Emblica officinalis and Ocimum sanctum. Anc Sci Life
;27:1‑6.
Saeed S, Tariq P. Antibacterial activities of Emblica officinalis and
Coriandrum sativum against Gram negative urinary pathogens. Pak
J Pharm Sci 2007;20:32‑5.
Saini A, Sharma S, Chhibber S. Protective efficacy of Emblica
officinalis against Klebsiella pneumoniae induced pneumonia in mice.
Indian J Med Res 2008;128:188‑93.
Thaweboon B, Thaweboon S. Effect of Phyllanthus emblica Linn. on
candida adhesion to oral epithelium and denture acrylic. Asian
Pac J Trop Med 2011;4:41‑5.
Bagavan A, Rahuman AA, Kaushik NK, Sahal D. In vitro
antimalarial activity of medicinal plant extracts against
Plasmodium falciparum. Parasitol Res 2011;108:15‑22.
Pinmai K, Hiriote W, Soonthornchareonnon N, Jongsakul K,
Sireeratawong S, Tor‑Udom S. In vitro and in vivo antiplasmodial
activity and cytotoxicity of water extracts of Phyllanthus emblica,
Terminalia chebula, and Terminalia bellerica. J Med Assoc Thai
;93:S120‑6.
Xiang Y, Pei Y, Qu C, Lai Z, Ren Z, Yang K, et al. In vitro anti‑herpes
simplex virus activity of 1,2,4,6‑tetra‑O‑galloyl‑β‑D‑glucose from
Phyllanthus emblica L. (Euphorbiaceae). Phytother Res 2011;25:975‑82.
Kumar A, Tantry BA, Rahiman S, Gupta U. Comparative study of
antimicrobial activity and phytochemical analysis of methanolic
and aqueous extracts of the fruit of Emblica officinalis against
pathogenic bacteria. J Tradit Chin Med 2011;31:246‑50.
Nandagopal B, Sankar S, Ramamurthy M, Sathish S, Sridharan G.
Could the products of Indian medicinal plants be the next
alternative for the treatment of infections? Indian J Med Microbiol
;29:93‑101.
Shynu M, Gupta PK, Saini M. Antineoplastic potential of medicinal
plants. Recent Pat Biotechnol 2011;5:85‑94.
Asensi M, Ortega A, Mena S, Feddi F, Estrela JM. Natural
polyphenols in cancer therapy. Crit Rev Clin Lab Sci 2011;48:197‑216.
Ngamkitidechakul C, Jaijoy K, Hansakul P, Soonthornchareonnon N,
Sireeratawong S. Antitumour effects of Phyllanthus emblica L.:
Induction of cancer cell apoptosis and inhibition of in vivo tumour
promotion and in vitro invasion of human cancer cells. Phytother
Res 2010;24:1405‑13.
Sancheti G, Jindal A, Kumari R, Goyal PK. Chemopreventive
action of Emblica officinalis on skin carcinogenesis in mice. Asian
Pac J Cancer Prev 2005;6:197‑201.
Huang JL, Zhong ZG. Study of galic acid extracted from the
leaves of Phyllanthus emblica on apoptotic mechanism of human
hepatocellular carcinoma cells BEL‑7404. Zhong Yao Cai
;34:246‑9.
Yang CJ, Wang CS, Hung JY, Huang HW, Chia YC, Wang PH,
et al. Pyrogallol induces G2‑M arrest in human lung cancer cells
and inhibits tumor growth in an animal model. Lung Cancer
;66:162‑8.
Banu SM, Selvendiran K, Singh JP, Sakthisekaran D. Protective effect
of Emblica officinalis ethanolic extract against 7,12‑dimethylbenz(a)
anthracene (DMBA) induced genotoxicity in Swiss albino mice.
Hum Exp Toxicol 2004;23:527‑31.
Rajeshkumar NV, Pillai MR, Kuttan R. Induction of apoptosis
in mouse and human carcinoma cell lines by Emblica officinalis
polyphenols and its effect on chemical carcinogenesis. J Exp Clin
Cancer Res 2003;22:201‑12.
Zhang YJ, Nagao T, Tanaka T, Yang CR, Okabe H, Kouno I.
Antiproliferative activity of the main constituents from Phyllanthus
emblica. Biol Pharm Bull 2004;27:251‑5.
Haque R, Bin‑Hafeez B, Ahmad I, Parvez S, Pandey S,
Raisuddin S. Protective effects of Emblica officinalis Gaertn.
in cyclophosphamide‑treated mice. Hum Exp Toxicol
;20:643‑50.
Jindal A, Soyal D, Sharma A, Goyal PK. Protective effect of an
extract of Emblica officinalis against radiation‑induced damage in
mice. Integr Cancer Ther 2009;8:98‑105.
Sultana S, Ahmed S, Jahangir T. Emblica officinalis and
hepatocarcinogenesis: A chemopreventive study in Wistar rats.
J Ethnopharmacol 2008;118:1‑6.
Singh I, Soyal D, Goyal PK. Emblica officinalis (Linn.) fruit extract
provides protection against radiation‑induced hematological and
biochemical alterations in mice. J Environ Pathol Toxicol Oncol
;25:643‑54.
Singh I, Sharma A, Nunia V, Goyal PK. Radioprotection of Swiss
albino mice by Emblica officinalis. Phytother Res 2005;19:444‑6.
Calixto JB, Campos MM, Otuki MF, Santos AR. Anti‑inflammatory
compounds of plant origin. Part II. modulation of pro‑inflammatory
cytokines, chemokines and adhesion molecules. Planta Med
;70:93‑103.
Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H.
Anti‑inflammatory activities of Emblica officinalis Gaertn leaf
extracts. J Pharm Pharmacol 1993;45:581‑4.
Perianayagam JB, Sharma SK, Joseph A, Christina AJ. Evaluation
of anti‑pyretic and analgesic activity of Emblica officinalis Gaertn.
J Ethnopharmacol 2004;95:83‑5.
Muthuraman A, Sood S, Singla SK. The antiinflammatory
potential of phenolic compounds from Emblica officinalis L. in rat.
Inflammopharmacology 2011;19:327‑34.
Dang GK, Parekar RR, Kamat SK, Scindia AM, Rege NN.
Antiinflammatory activity of Phyllanthus emblica, Plumbago
zeylanica and Cyperus rotundus in acute models of inflammation.
Phytother Res 2011;25:904‑8.
Penolazzi L, Lampronti I, Borgatti M, Khan MT, Zennaro M, Piva R,
et al. Induction of apoptosis of human primary osteoclasts treated
with extracts from the medicinal plant Emblica officinalis. BMC
Complement Altern Med 2008;8:59.
Sumantran VN, Kulkarni A, Chandwaskar R, Harsulkar A,
Patwardhan B, Chopra A, et al. Chondroprotective Potential of
Fruit Extracts of Phyllanthus emblica in Osteoarthritis. Evid Based
Complement Alternat Med 2008;5:329‑35.
Romano M, Vitaglione P, Sellitto S, D’Argenio G. Nutraceuticals
for protection and healing of gastrointestinal mucosa. Curr Med
Chem 2012;19:109‑17.
Chatterjee A, Chattopadhyay S, Bandyopadhyay SK. Biphasic
Effect of Phyllanthus emblica L. Extract on NSAID‑Induced Ulcer:
An antioxidative trail weaved with immunomodulatory effect.
Evid Based Complement Alternat Med 2011;2011:146808.
Bandyopadhyay SK, Pakrashi SC, Pakrashi A. The role of
antioxidant activity of Phyllanthus emblica fruits on prevention
from indomethacin induced gastric ulcer. J Ethnopharmacol
;70:171‑6.
Sairam K, Rao ChV, Babu MD, Kumar KV, Agrawal VK, Goel RK.
Antiulcerogenic effect of methanolic extract of Emblica officinalis:
An experimental study. J Ethnopharmacol 2002;82:1‑9.
Mehmood MH, Siddiqi HS, Gilani AH. The antidiarrheal and
spasmolytic activities of Phyllanthus emblica are mediated through
dual blockade of muscarinic receptors and Ca2+channels.
J Ethnopharmacol 2011;133:856‑65.
Sidhu S, Pandhi P, Malhotra S, Vaiphei K, Khanduja KL. Beneficial
effects of Emblica officinalis in L‑arginine‑induced acute pancreatitis
in rats. J Med Food 2011;14:147‑55.
Thorat SP, Rege NN, Naik AS, Thatte UM, Joshi A, Panicker KN,
et al. Emblica officinalis: A novel therapy for acute pancreatitis – An
experimental study. HPB Surg 1995;9:25‑30.
Fowler JF Jr, Woolery‑Lloyd H, Waldorf H, Saini R. Innovations
in natural ingredients and their use in skin care. J Drugs Dermatol
;9:S72‑81.
Reuter J, Merfort I, Schempp CM. Botanicals in dermatology: An
evidence‑based review. Am J Clin Dermatol 2010;11:247‑67.
Fujii T, Wakaizumi M, Ikami T, Saito M. Amla (Emblica
officinalis Gaertn.) extract promotes procollagen production and
inhibits matrix metalloproteinase‑1 in human skin fibroblasts.
J Ethnopharmacol 2008;119:53‑7.
Majeed M, Bhat B, Anand S, Sivakumar A, Paliwal P, Geetha KG.
Inhibition of UV‑induced ROS and collagen damage by Phyllanthus
emblica extract in normal human dermal fibroblasts. J Cosmet Sci
;62:49‑56.
Adil MD, Kaiser P, Satti NK, Zargar AM, Vishwakarma RA,
Tasduq SA. Effect of Emblica officinalis (fruit) against UVB‑induced
photo‑aging in human skin fibroblasts. J Ethnopharmacol
;132:109‑14.
Draelos ZD, Yatskayer M, Bhushan P, Pillai S, Oresajo C. Evaluation
of a kojic acid, emblica extract, and glycolic acid formulation
compared with hydroquinone 4% for skin lightening. Cutis
;86:153‑8.
Sumitra M, Manikandan P, Gayathri VS, Mahendran P,
Suguna L. Emblica officinalis exerts wound healing action through
up‑regulation of collagen and extracellular signal‑regulated
kinases (ERK1/2). Wound Repair Regen 2009;17:99‑107.
Chaudhuri RK. Emblica cascading antioxidant: A novel natural skin
care ingredient. Skin Pharmacol Appl Skin Physiol 2002;15:374‑80.
Kumar V. Potential medicinal plants for CNS disorders: An
overview. Phytother Res 2006;20:1023‑35.
Kulkarni AP, Kellaway LA, Kotwal GJ. Herbal complement
inhibitors in the treatment of neuroinflammation: Future strategy
for neuroprotection. Ann N Y Acad Sci 2005;1056:413‑29.
Bhattacharya A, Ghosal S, Bhattacharya SK. Antioxidant activity
of tannoid principles of Emblica officinalis (amla) in chronic stress
induced changes in rat brain. Indian J Exp Biol 2000;38:877‑80.
Bhattachary SK, Bhattacharya D, Muruganandam AV. Effect of
Emblica officinalis tannoids on a rat model of tardive dyskinesia.
Indian J Exp Biol 2000;38:945‑7.
Dhingra D, Joshi P, Gupta A, Chhillar R. Possible involvement
of monoaminergic neurotransmission in antidepressant‑like
activity of Emblica officinalis fruits in mice. CNS Neurosci Ther
;18:419‑25.
Reddy VD, Padmavathi P, Kavitha G, Gopi S, Varadacharyulu N.
Emblica officinalis ameliorates alcohol‑induced brain mitochondrial
dysfunction in rats. J Med Food 2011;14:62‑8.
Golechha M, Bhatia J, Arya DS. Hydroalcoholic extract of Emblica
officinalis Gaertn. affords protection against PTZ‑induced seizures,
oxidative stress and cognitive impairment in rats. Indian J Exp Biol
;48:474‑8.
Vasudevan M, Parle M. Effect of Anwala churna (Emblica officinalis
GAERTN.): An ayurvedic preparation on memory deficit rats.
Yakugaku Zasshi 2007;127:1701‑7.
Vasudevan M, Parle M. Memory enhancing activity of Anwala
churna (Emblica officinalis Gaertn.): An Ayurvedic preparation.
Physiol Behav 2007;91:46‑54.
Perry E, Howes MJ. Medicinal plants and dementia therapy: Herbal
hopes for brain aging? CNS Neurosci Ther 2011;17:683‑98.
Chanvorachote P, Pongrakhananon V, Luanpitpong S,
Chanvorachote B, Wannachaiyasit S, Nimmannit U. Type I
pro‑collagen promoting and anti‑collagenase activities of
Phyllanthus emblica extract in mouse fibroblasts. J Cosmet Sci
;60:395‑403.
Head KA. Natural therapies for ocular disorders, part two:
Cataracts and glaucoma. Altern Med Rev 2001;6:141‑66.
Suryanarayana P, Kumar PA, Saraswat M, Petrash JM, Reddy GB.
Inhibition of aldose reductase by tannoid principles of Emblica
officinalis: Implications for the prevention of sugar cataract. Mol
Vis 2004;10:148‑54.
Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica
officinalis and its enriched tannoids delay streptozotocin‑induced
diabetic cataract in rats. Mol Vis 2007;13:1291‑7.
Chakraborty D, Verma R. Spermatotoxic effect of ochratoxin and
its amelioration by Emblica officinalis aqueous extract. Acta Pol
Pharm 2009;66:689‑95.
Madhavi D, Devil KR, Rao KK, Reddy PP. Modulating effect of
Phyllanthus fruit extract against lead genotoxicity in germ cells
of mice. J Environ Biol 2007;28:115‑7.
Nosál’ová G, Mokrý J, Hassan KM. Antitussive activity of
the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae).
Phytomedicine 2003;10:583‑9.
Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini A,
Bianchi N, et al. Pyrogallol, an active compound from the medicinal
plant Emblica officinalis, regulates expression of pro‑inflammatory
genes in bronchial epithelial cells. Int Immunopharmacol
;8:1672‑80.
Panda S, Kar A. Fruit extract of Emblica officinalis ameliorates
hyperthyroidism and hepatic lipid peroxidation in mice.
Pharmazie 2003;58:753‑5.
De Smet PA. The role of plant‑derived drugs and herbal medicines
in healthcare. Drugs 1997;54:801‑40.
Akerele O. Nature’s medicinal bounty: Don’t throw it away. World
Health Forum 1993;14:390‑5.
DOI: https://doi.org/10.22377/ijgp.v6i4.272
Refbacks
- There are currently no refbacks.
 | |
About us | Contact us | Sitemap | Advertise | What's New | Feedback | Copyright and Disclaimer | Â |
© 2014 International Journal of Green Pharmacy | Hosted and Maintained by BRNSS Publication Hub | |
Online since 15th February, 2008 www.brncop.org | www.asiapharmaceutics.info | www.aiip.info | |
 |